Trial Profile
Insulin glargine [rDNA origin] injection vs pioglitazone as add-on therapy in patients failing monotherapy with sulfonylurea or metformin: a randomized, open, parallel study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2011
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 18 Oct 2006 New trial record.